Financials Minerva Surgical, Inc.

Equities

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 09:48:24 2024-02-28 am EST 5-day change 1st Jan Change
0.66 USD +1.54% Intraday chart for Minerva Surgical, Inc. +6.28% -43.59%

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 148.1 6.58
Enterprise Value (EV) 1 146.8 39.33
P/E ratio -1.68 x -0.19 x
Yield - -
Capitalization / Revenue 2.84 x 0.13 x
EV / Revenue 2.82 x 0.78 x
EV / EBITDA -8.11 x -1.35 x
EV / FCF -7,198,359 x -2,691,966 x
FCF Yield -0% -0%
Price to Book 3.36 x 0.39 x
Nbr of stocks (in thousands) 1,441 1,473
Reference price 2 102.8 4.468
Announcement Date 3/23/22 3/22/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales 1 26.01 37.77 52.1 50.29
EBITDA 1 -17.96 -7.489 -18.1 -29.19
EBIT 1 -19.64 -14.56 -28.72 -39.99
Operating Margin -75.49% -38.56% -55.12% -79.52%
Earnings before Tax (EBT) 1 -52.05 -18.4 -21.46 -34.1
Net income 1 -52.05 -18.26 -21.46 -34.11
Net margin -200.08% -48.36% -41.2% -67.83%
EPS 2 -1,155 -378.3 -61.22 -23.68
Free Cash Flow - -0.8456 -20.39 -14.61
FCF margin - -2.24% -39.14% -29.05%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 9/27/21 9/27/21 3/23/22 3/22/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 12.51 13.64 10.94 12.97 12.59 13.8 12.53 13.39 11.96
EBITDA 1 -2.589 -6.654 -10.3 -4.899 -5.841 -5.672 -6.525 -4.579 -3.819
EBIT 1 -6.14 -6.654 -10.3 -4.899 -10.51 -5.192 -10.31 -7.658 -6.096
Operating Margin -49.1% -48.77% -94.19% -37.78% -83.48% -37.61% -82.26% -57.19% -50.95%
Earnings before Tax (EBT) 1 -3.225 10.82 -10.92 -5.613 -11.33 -6.234 -11.34 -8.642 -7.178
Net income 1 -3.225 10.81 -10.92 -5.613 -11.33 -6.234 -11.34 -8.681 -7.181
Net margin -25.79% 79.21% -99.91% -43.29% -90% -45.16% -90.51% -64.83% -60.02%
EPS 2 -2.240 7.500 -7.600 -4.000 -8.000 -4.000 -2.400 -1.000 -0.8100
Dividend per Share - - - - - - - - -
Announcement Date 12/2/21 3/8/22 5/11/22 8/9/22 11/14/22 3/22/23 5/2/23 8/2/23 11/13/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 48.9 80 - 32.7
Net Cash position 1 - - 1.33 -
Leverage (Debt/EBITDA) -2.721 x -10.68 x - -1.122 x
Free Cash Flow - -0.85 -20.4 -14.6
ROE (net income / shareholders' equity) - 20% 78.8% -111%
ROA (Net income/ Total Assets) - -13.1% -17.3% -27.2%
Assets 1 - 139.2 123.9 125.5
Book Value Per Share 2 -4,539 -3,720 30.60 11.50
Cash Flow per Share 2 601.0 291.0 28.20 4.660
Capex 1 0.22 0.45 0.58 0.07
Capex / Sales 0.86% 1.2% 1.12% 0.15%
Announcement Date 9/27/21 9/27/21 3/23/22 3/22/23
1USD in Million2USD
Estimates
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW